Apjohn Ventures
Early-stage venture capital fund investing in life sciences companies, primarily in the U.S. Midwest. Provides equity financing from seed through Series rounds, deal syndication, technical and clinical due diligence, board-level and operational support, and access to advisors with corporate finance and industry operational experience to advance portfolio companies toward exits (M&A or IPO).
Industries
finance
financial-services
venture-capital-b37d
Nr. of Employees
small (1-50)
Apjohn Ventures
350 E. Michigan Ave, Suite 500, Kalamazoo, MI 49007
Expertise Areas
- Early-stage venture investing in life sciences
- Scientific and technical due diligence
- Clinical development strategy
- Regulatory advisory and readiness
Key Technologies
- Oligonucleotide therapeutics
- Liposomal nanoparticle delivery systems
- Enzyme replacement therapies
- Drug-eluting stent delivery and bioabsorbable carriers